Clinical Trials
7
Active:6
Completed:0
Trial Phases
2 Phases
Phase 1:5
Phase 3:2
Drug Approvals
1
PPB:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Phase 1
5 (71.4%)Phase 3
2 (28.6%)Study of OT-101 in Treating Myopia
Phase 3
Active, not recruiting
- Conditions
- Myopia, Progressive
- Interventions
- Drug: OT-101 Ophthalmic SolutionDrug: Vehicle
- First Posted Date
- 2021-02-25
- Last Posted Date
- 2023-08-08
- Lead Sponsor
- Ocumension (Hong Kong) Limited
- Target Recruit Count
- 678
- Registration Number
- NCT04770610
- Locations
- 🇺🇸
Colorado Vision Institute, Colorado Springs, Colorado, United States
🇺🇸Eye Center of Northern Colorado, PC, Fort Collins, Colorado, United States
🇺🇸Family Focus, Gainesville, Florida, United States
News
No news found